If the ligand demonstrates promise in preclinical studies, it may proceed to human studies. This involves conducting PET imaging with the radiolabeled ligand in healthy subjects or patients to assess its safety and ability to bind to the D4 receptor in the human brain.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.